Brain, Vol. 126, No. 3, 685-691,
March 2003
© 2003 Guarantors of Brain
doi: 10.1093/brain/awg050
Gluten ataxia in perspective: epidemiology, genetic susceptibility and clinical characteristics
Departments of 1 Neurology and 2 Gastroenterology, The Royal Hallamshire Hospital, 3 Division of Biomedical Sciences, Sheffield Hallam University, Sheffield and 4 Department of Molecular Pathogenesis, Institute of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square, London, UK
Correspondence to: M. Hadjivassiliou, Department of Clinical Neurology, The Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, UK E-mail: m.hadjivassiliou{at}sheffield.ac.uk
We previously have described a group of patients with gluten sensitivity presenting with ataxia (gluten ataxia) and suggested that this disease entity may account for a large number of patients with sporadic idiopathic ataxia. We have therefore investigated the prevalence of gluten sensitivity amongst a large cohort of patients with sporadic and familial ataxia and looked at possible genetic predisposition to gluten sensitivity amongst these groups. Two hundred and twenty-four patients with various causes of ataxia from North Trent (59 familial and/or positive testing for spinocerebellar ataxias 1, 2, 3, 6 and 7, and Friedreich’s ataxia, 132 sporadic idiopathic and 33 clinically probable cerebellar variant of multiple system atrophy MSA-C) and 44 patients with sporadic idiopathic ataxia from The Institute of Neurology, London, were screened for the presence of antigliadin antibodies. A total of 1200 volunteers were screened as normal controls. The prevalence of antigliadin antibodies in the familial group was eight out of 59 (14%), 54 out of 132 (41%) in the sporadic idiopathic group, five out of 33 (15%) in the MSA-C group and 149 out of 1200 (12%) in the normal controls. The prevalence in the sporadic idiopathic group from London was 14 out of 44 (32%). The difference in prevalence between the idiopathic sporadic groups and the other groups was highly significant (P < 0.0001 and P < 0.003, respectively). The clinical characteristics of 68 patients with gluten ataxia were as follows: the mean age at onset of the ataxia was 48 years (range 14–81 years) with a mean duration of the ataxia of 9.7 years (range 1–40 years). Ocular signs were observed in 84% and dysarthria in 66%. Upper limb ataxia was evident in 75%, lower limb ataxia in 90% and gait ataxia in 100% of patients. Gastrointestinal symptoms were present in only 13%. MRI revealed atrophy of the cerebellum in 79% and white matter hyperintensities in 19%. Forty-five percent of patients had neurophysiological evidence of a sensorimotor axonal neuropathy. Gluten-sensitive enteropathy was found in 24%. HLA DQ2 was present in 72% of patients. Gluten ataxia is therefore the single most common cause of sporadic idiopathic ataxia. Antigliadin antibody testing is essential at first presentation of patients with sporadic ataxia.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G Grossman Neurological complications of coeliac disease: what is the evidence? Practical Neurology, April 1, 2008; 8(2): 77 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L E Almaguer-Mederos, Y R Almira, E M Gongora, D A Gotay, Y G Zaldivar, R E Pupo, G S Cruz, J M Brown, D C Almarales, and L V Perez Antigliadin antibodies in Cuban patients with spinocerebellar ataxia type 2 J. Neurol. Neurosurg. Psychiatry, March 1, 2008; 79(3): 315 - 317. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Ch'ng, M. K. Jones, and J. G. C. Kingham Celiac Disease and Autoimmune Thyroid Disease Clin. Med. Res., October 1, 2007; 5(3): 184 - 192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Hadjivassiliou, R A Grunewald, R H Kandler, A K Chattopadhyay, J A Jarratt, D S Sanders, B Sharrack, S B Wharton, and G A B Davies-Jones Neuropathy associated with gluten sensitivity J. Neurol. Neurosurg. Psychiatry, November 1, 2006; 77(11): 1262 - 1266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A J Wills, D S N A Pengiran Tengah, and G K T Holmes The neurology of enteric disease J. Neurol. Neurosurg. Psychiatry, July 1, 2006; 77(7): 805 - 810. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hadjivassiliou, M. Maki, D. S. Sanders, C. A. Williamson, R. A. Grunewald, N. M. Woodroofe, and I. R. Korponay-Szabo Autoantibody targeting of brain and intestinal transglutaminase in gluten ataxia Neurology, February 14, 2006; 66(3): 373 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R J Lock, D S N A Pengiran Tengah, D J Unsworth, J J Ward, and A J Wills Ataxia, peripheral neuropathy, and anti-gliadin antibody. Guilt by association? J. Neurol. Neurosurg. Psychiatry, November 1, 2005; 76(11): 1601 - 1603. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N R Rosenberg and M Vermeulen Should coeliac disease be considered in the work up of patients with chronic peripheral neuropathy? J. Neurol. Neurosurg. Psychiatry, October 1, 2005; 76(10): 1415 - 1419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I D Wilkinson, M Hadjivassiliou, J M Dickson, L Wallis, R A Grunewald, S C Coley, E Widjaja, and P D Griffiths Cerebellar abnormalities on proton MR spectroscopy in gluten ataxia J. Neurol. Neurosurg. Psychiatry, July 1, 2005; 76(7): 1011 - 1013. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hadjivassiliou, D. S. Sanders, R. A. Grunewald, A. J. Wills, D. J. Unsworth, R. J. Lock, and C. D.S.N.A. Pengiran Tengah Multiple sclerosis and occult gluten sensitivity Neurology, March 8, 2005; 64(5): 933 - 934. [Full Text] [PDF]
|
|
|
|
 |
|
 M Hadjivassiliou, D S Sanders, R A Grunewald, and M Akil Gluten sensitivity masquerading as systemic lupus erythematosus Ann Rheum Dis, November 1, 2004; 63(11): 1501 - 1503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Bushara, M. Hallett, T. Klockgether, and M. Abele Prevalence of antigliadin antibodies in ataxia patients Neurology, April 13, 2004; 62(7): 1237 - 1238. [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Migliaccio, G. M. Halmagyi, L. A. McGarvie, and P. D. Cremer Cerebellar ataxia with bilateral vestibulopathy: description of a syndrome and its characteristic clinical sign Brain, February 1, 2004; 127(2): 280 - 293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Wills and D. J. Unsworth Gluten ataxia 'in perspective' Brain, September 1, 2003; 126(9): E4 - E4. [Full Text] [PDF]
|
|
|
|
|
|
M Hadjivassiliou, G A B Davies-Jones, D S Sanders, and R A Grunewald Dietary treatment of gluten ataxia J. Neurol. Neurosurg. Psychiatry, September 1, 2003; 74(9): 1221 - 1224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Lucina Arch. Dis. Child., August 1, 2003; 88(8): 744 - 744. [Full Text] [PDF]
|
|
|
|
|
|
A. H. Cross and P. T. Golumbek Neurologic manifestations of celiac disease: Proven, or just a gut feeling? Neurology, May 27, 2003; 60(10): 1566 - 1568. [Full Text] [PDF]
|
|